文献速递消化道肿瘤放疗放疗物理与技术

骨骼肌影像组学有助于预测接受新辅助放化疗的局部晚期直肠癌患者的胃肠道毒性

Radiomics of skeletal muscle helps to predict gastrointestinal toxicity in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy.
PubMed 文献 · Clin Transl Radiat Oncol · 2023-11-20

本研究回顾性纳入214例接受卡培他滨联合伊立替康新辅助盆腔放疗的直肠癌患者,从第三腰椎水平骨骼肌CT提取影像组学特征,构建结合骨骼肌指数(SMI)与影像组学特征的逻辑回归模型预测3-4级胃肠道毒性。联合模型在训练集、内部验证集和外部验证集的AUC分别为0.856、0.812和0.745,优于单独SMI,决策曲线分析验证了其临床实用性。

要点

  • 骨骼肌影像组学特征与接受新辅助放化疗的直肠癌患者3-4级胃肠道毒性显著相关。
  • 联合SMI与影像组学特征的模型在训练集、内部验证集和外部验证集的AUC分别为0.856、0.812和0.745。
  • 联合模型区分度优于单独SMI,决策曲线分析验证其临床实用性。

核心结论

  • 骨骼肌影像组学特征与胃肠道毒性显著相关,结合SMI与影像组学特征的预测模型表现出良好的区分度,可能对临床决策具有高度信息价值。

研究设计与样本

  • 回顾性识别214例接受卡培他滨联合伊立替康新辅助盆腔放疗的直肠癌患者,训练集115例、内部验证集49例、外部验证集50例。
  • 勾画第三腰椎水平骨骼肌,从CT扫描提取影像组学特征,在训练集中采用LASSO回归筛选与3-4级胃肠道毒性最显著相关的特征。
  • 采用受试者工作特征曲线下面积(AUC)、F1分数和决策曲线分析(DCA)评估预测性能和临床实用性。

主要发现

  • 9个特征(包括SMI和8个影像组学特征)与3-4级胃肠道毒性相关并纳入逻辑回归。
  • 联合预测模型在训练队列的AUC为0.856(95%CI:0.782-0.929),内部验证队列为0.812(95%CI:0.667-0.956),外部验证队列为0.745(95%CI:0.600-0.890)。
  • 联合预测模型区分度优于单独SMI,DCA进一步验证了联合预测模型的临床实用性。

关键数值与推荐

  • 3-4级胃肠道毒性包括腹泻、恶心、呕吐和直肠炎。
  • 联合模型AUC:训练队列0.856(95%CI:0.782-0.929)、内部验证队列0.812(95%CI:0.667-0.956)、外部验证队列0.745(95%CI:0.600-0.890)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The skeletal muscle index (SMI) can serve as a surrogate for a patient's nutritional status, which is associated with treatment toxicity. This study aims to investigate the potential of baseline skeletal muscle radiomics features to predict gastrointestinal toxicity of neoadjuvant chemoradiotherapy for rectal cancer. METHODS: A total of 214 rectal cancer patients (115, 49 and 50 in the training, internal and external validation set, respectively) who underwent neoadjuvant pelvic radiotherapy with capecitabine and irinotecan were retrospectively identified. The skeletal muscle at the level of the third lumber vertebra was contoured, and the radiomics features were extracted from computed tomography scans. In the training set, the least absolute shrinkage and selection operator (LASSO) regression algorithm was applied to select features that were most significantly associated with grade 3-4 gastrointestinal toxicity (diarrhea, nausea, vomiting and proctitis). The predictive performance and clinical utility were estimated using the area under the receiver operator characteristic curve (AUC), F1-score and decision curve analysis (DCA). RESULTS: Nine features, including the SMI and eight radiomics features, were associated with grade 3-4 gastrointestinal toxicity and included in the logistic regression. This combined predictive model, which incorporated the SMI and radiomics features, showed better discrimination than the SMI alone, with an AUC of 0.856 (95 % CI: 0.782-0.929) in the training cohort, 0.812 (95 % CI: 0.667-0.956) in the internal validation cohort and 0.745 (95 % CI: 0.600-0.890) in the external validation cohort. DCA further verified the clinical utility of the combined predictive model. CONCLUSION: Radiomics features of skeletal muscle were significantly associated with gastrointestinal toxicity. The predictive model incorporating the SMI and radiomics features exhibits favorable discrimination and may be highly informative for clinical decision-makings.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Yang W, Zhang Z, Zhou M, et al. Radiomics of skeletal muscle helps to predict gastrointestinal toxicity in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy. Clin Transl Radiat Oncol. 2023. PMID: 38073716. doi:10.1016/j.ctro.2023.100703

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。